pharmaceutical investing Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection
Kobo Resources Strengthens Gold Mineralisation at Kossou Intersecting 9.0 m at 3.60 g/t Au and 8.0 m at 2.54 g/t Au
